Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Holding back the News. Or Not Any News at All
*tried…
Wondering if this just keep calm and carry on ?
Anybody tries to call them ?
Under actual institutional owners, it does say this, but also mentions this:
Related US8677814035 / Sunshine Biopharma Inc (18 owners) (from prior post) and
Institutional Owners 0 total, 0 long only, 0 short only, 0 long/short - change of -100.00% MRQ
According to fintel.io, 4 institutional owners have left:
Jane Street Group, Llc closes position in US8677814035 / Sunshine Biopharma Inc
Security US8677814035 / Sunshine Biopharma Inc
Institution Jane Street Group, Llc
Latest Disclosed Ownership 0 shares
Latest Disclosed Value $ 0
Related SBFM / Sunshine Biopharma, Inc.
Armistice Capital, Llc closes position in US8677814035 / Sunshine Biopharma Inc
Security US8677814035 / Sunshine Biopharma Inc
Institution Armistice Capital, Llc
Manager Steven Boyd
Latest Disclosed Ownership 0 shares
Latest Disclosed Value $ 0
Related SBFM / Sunshine Biopharma, Inc.
Hudson Bay Capital Management LP closes position in US8677814035 / Sunshine Biopharma Inc
Security US8677814035 / Sunshine Biopharma Inc
Institution Hudson Bay Capital Management LP
Latest Disclosed Ownership 0 shares
Latest Disclosed Value $ 0
Related SBFM / Sunshine Biopharma, Inc.
Hudson Bay Capital Management LP closes position in US8677814035 / Sunshine Biopharma Inc
2022-08-12 - Hudson Bay Capital Management LP has filed a 13F-HR form disclosing ownership of 0 shares of Sunshine Biopharma Inc (US:US8677814035) with total holdings valued at $0 USD as of 2022-06-30. Hudson Bay Capital Management LP had filed a previous 13F-HR on 2022-05-16 disclosing 315,000 shares of Sunshine Biopharma Inc at a value of $720,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter.
Empery Asset Management, LP closes position in US8677814035 / Sunshine Biopharma Inc
Security US8677814035 / Sunshine Biopharma Inc
Institution Empery Asset Management, LP
Manager Ryan Matthew Lane and Martin David Hoe
Latest Disclosed Ownership 0 shares
Latest Disclosed Value $ 0
Related SBFM / Sunshine Biopharma, Inc.
Empery Asset Management, LP closes position in US8677814035 / Sunshine Biopharma Inc
2022-08-12 - Empery Asset Management, LP has filed a 13F-HR form disclosing ownership of 0 shares of Sunshine Biopharma Inc (US:US8677814035) with total holdings valued at $0 USD as of 2022-06-30. Empery Asset Management, LP had filed a previous 13F-HR on 2022-05-16 disclosing 450,450 shares of Sunshine Biopharma Inc at a value of $1,104,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter.
Well I guess whoever gave them 40 million not worth that today
Personally I don’t think they ever where doing any real mice studies . The only studying I believe they were doing was putting out a plan to fill there pockets At our expense . Communicate with investors up to the rs, and uplist , then cut all communication . Glad I’m out.
The stamina these senior citizens have, Dr Slilaty, some weirdo named Camille who keeps spilling the beans and screwing up SEC filings, and that virology doctor.
The press release from a few days ago really does say this!!
Already a player in the oncology and antiviral spaces, Sunshine is starting to make a name for itself in the $152 billion dietary supplement market with the launch of its science-based Essential 9TM capsule. The amino acid supplement saw nearly 200% growth in sales in the first half of this year compared to the same period in 2021.
smhsmhsmh
No REGERTS selling at .07 pre split still lol
10% of share holders could force this company to release essentially all information by way of a demand letter. If they refused, it could lead to a material event violation if they even still exist.
Maybe next week they’ll tell us about their two FDA apps and patents since 2020, if they are more interested in being the next GNC or Merck Health, and why they have a fake virtual office with Regus with free coffee and faxing instead of a real office with $40M on the books.
and why all of them had to file PPP loans in the US as a primary Canadian citizen and resident… What about the Canada PPP loan?
This what you don’t do. File an IND or any FDA application and then put out a PR saying:
“Adva-27a is expected to enter Phase I clinical trials for pancreatic cancer and multidrug resistant breast cancer following completion of the GMP manufacturing and formulation of a 2-kilograms quantity for injection”
Phase 1:
During Phase 1 studies, researchers generally test a new drug candidate in healthy volunteers (healthy people). In most cases, 20 to 80 healthy volunteers participate in Phase 1.
The primary purpose of a Phase 1 study is to evaluate the safety of a new drug candidate before it proceeds to further clinical studies. In addition to safety, researchers can answer other questions in a Phase 1 trial related to how much drug is measured in the blood after administration, how the drug works in the body and the side effects associated with increased dosage.
We know they are only doing research on mice and perhaps human cells. Nowhere near Phase 1.
Thanks only thing I can pray these guys don’t run into some new neurotic discovery or oxidative vaccine or some 10th vitamin and lose focus.
I hope they deliver exactly what the money has been raised in a responsible manner without any seemingly gimmicky encounters.
Jmo
And they withdrew in March 2022, their $1M+, along with 2 other institutional investors.
That right there is a *BAD* PR dated 9/13/2022 and is 100% false, afaik. The type that would get someone fired.
It may be another paid promo, but it’s such a weird PR that I don’t think SBFM would be that stupid. This guy who wrote it should be questioned:
Posted by Stuart Ham on Sep 13th, 2022
Who sold out of Sunshine Biopharma?
Fund or Company Name Date Sold Shares Held Valued At
Empery Asset Management Mar 2022 451k $1.1M
Hudson Bay Capital Management Mar 2022 315k $720k
Jane Street Mar 2022 13k $31k
This is what we are waiting for from SBFM: "Adva-27a is expected to enter Phase I clinical trials for pancreatic cancer and multidrug resistant breast cancer following completion of the GMP manufacturing and formulation of a 2-kilograms quantity for injection."
I would think an update on this is forthcoming within the next 4 months. By then we should also have an indication of the status of the NAS listing. If both are positive then good for those who have bought and held. If not, then all bets are off.
No idea but I think existing shorts may be or start covering resulting in a price surge in the event it keeps falling.
Emprey was a Hedge Fund correct? Could they have taken a short position ?
If sunshine gets sued or even worse indicted, this probably will go negative. Not enough cash or assets, even with a billion dollar eval by a leading accounting company. They never had a billion bucks, probably not even $100M.
Not saying it will, but it makes me cautious especially with at least 3 institutional investors that all pulled out in March.
What the heck happened in March?????
It would be really nice to know what their reasoning is and if this would be considered a material event that must be disclosed, within 3 business days? Is that right?
Empery quickly ended their investment of over $1M with Sunshine as well as other institutional investors
Who sold out of Sunshine Biopharma?
Fund or Company Name Date Sold Shares Held Valued At
Empery Asset Management Mar 2022 451k $1.1M
Hudson Bay Capital Management Mar 2022 315k $720k
Jane Street Mar 2022 13k $31k
That would be the bad news. The good news would be SBFM is ready to start clinical trials (of cancer treatment) in early 2023 leading to FDA compassionate use authorization in late 2023! Just sayin' it can go either way or somewhere in between. 4-7 months of patience to find out whether they stay listed on the NAS and if they do have a cancer drug ready for human clinical trials in 2023.
This is bad. I don’t think they are answering or defending themselves. If for some reason it’s proven SBFM scammed investors, all their loans, debts, convertibles, may get called in.. just sayin
Was SBFM on the NAS back then or is this the new part this time around?
Great, that gives SBFM 7 months to show the goods! That would be April 2023. I think we'll get a significant update (good or bad) by January 2023. We'll also know if the stock price is going back up by then!
4-7 months until we know if SBFM is a make the bank or break the bank stock.
“If a company trades for 30 consecutive business days below the $1.00 minimum closing bid price requirement, Nasdaq will send a deficiency notice to the company, advising that it has been afforded a "compliance period" of 180 calendar days to regain compliance with the applicable requirements”
At least you didn't hold on to MULN
lol
Sub $1...how long before it gets delisted if it trades like that? 30 days? 90 days?
On 3/31/2017, SBFM Market Cap: 1,722,864
Not sure about the share structure, but based on this, they were worth between $977M and $1,133M ($1.13B) dollars based on this "estimated evaluation" of the audited paperwork as of 3/31/2017.
"The Company today received the results of an independent valuation it had commissioned on its issued and outstanding shares. MNP LLP ("MNP") was retained to provide a Valuation Report (the "Report") on the estimated en bloc Fair Market Value at March 31, 2017 of its issued and outstanding shares. The value arrived at in the Report was in the range of $977.0 million to $1,133.0 million. The Company had commissioned the Report as part of an obligation it had previously made to investors."
They cite a research article, unrelated to Sunshine BioPharma, dated 2012 that is only by these people:
ABDERRAZZAK MERZOUKI, MICHAEL D. BUSCHMANN, MYRIAM JEAN, REBECCA S. YOUNG, SI LIAO, SUSANNAH GAL, ZUOMEI LI and STEVE N. SLILATY
Anticancer Research October 2012, 32 (10) 4423-4432;
I'd like to know what the issued share count was, but as stated, the evaluation was only "estimated" and not "actual." Somehow, they were able to inflate the stock price, perhaps either by a very high share structure, or by stating this is what we'd be worth if we raise our share structure, and here is the paperwork to prove it thanks to "adva-27a" and other things.
SBFM completed the acquisition of "Atlas", the pharmaceutical company in January of 2018, but I'd like to know when that Letter of Intent was signed, because it may have played a role in their evaluation as well. And then they sell it right back?
Steve Slilaty sold Advanomics Corp for allegedly around $1B or something like that while the stock price and market cap was very high.
However, I believe he only walked away with a bit of cash and the worthless adva-27a patent that he was able to get the Canadian auditing firm (mnp.ca — The Mpact CPA) to value Sunshine at around $1,000,000,000 ($1 billion)
All he had to do was submit the correct paperwork that said adva27a was worth an estimated billion bucks and perhaps his ownership and sale of Advanomics, and I believe they owned a pharmaceutical manufacturing plant that they used along with other contracts that fell through to get such a high valuation. Then they sold the pharmaceutical plant right back to the same owner.
I think this is how all this unfolded to mislead investors into thinking a worthless company was worth at least around $1B which paved the path to where it is today.
MPN audited the documents and paperwork that was submitted, but they don’t have to verify the accuracy. There is a HUGE problem here.
If SBFM decided to liquidate and dilute, they’d be hit with a potential 30% tax liability.
At $18M, that’s be around $12.6M. And it’s worse than that, if they dilute their PPS will tank further, most likely dropping the market cap well below $10M
It’s just a hypothetical scenario, but financially, I don’t think they can recover and why would anyone bail them out or loan them money?
If you look at the positive side, which I write off as almost impossible, SBFM has to save the world with 3rd party vitamins it sells on Amazon.
The other way is to save the world with adva-27a or covid. In 12-18 months.
The positives and trying to be hopeful far exceed reality.
I’ve never seen such a high volatility rating and I’ve never seen a stock that was able to recover which such a rating, and I play penny stocks!!!!
My stock broker literally has listed SBFM as the worst performing, most volatile (extreme) stock I’ve ever had in my portfolio. I don’t think it’s even possible to right how bad this is tanking.
(SBFM: Sunshine BioPharma)
Historical Volatility Rating: 242.32%
Market cap: $18.67M
Earnings per share (EPS): -$1.60
This is what is frightening to me.
EPS definition: The higher a company's EPS, the more profitable it is considered to be. (-$1.60 exceeds the current price by more than 50 cents. Does that mean it’s worth about $-0.63 cents-ish as of today?)
Volatility rating definition: Volatility is a statistical measure of the dispersion of returns for a given security or market index. In most cases, the higher the volatility, the riskier the security. Volatility is often measured from either the standard deviation or variance between returns from that same security or market index.
30 more days until a delisting notification is filed if this trend continues. Then back to sub pennies.
Will this reverse split? Likely not, these crooks are done and rich.
They’ve been estimating 12-18 months and recycling that for 11 years. If you’ve held on that long, your total gain is -100%.
SBFM, still going strong even at sub dollar prices!
This is hilarious, someone posted on stocktwits
He realized dr slilatcrap runs companies strait to the ground, he ran a billion dollar company to bankruptcy all companies in his biography are bankrupt, jail is where he belongs
Keep waiting…dr slilatcrap will fill up his pockets and will pull the plug, just like all the rest of his companies he ran strait to the ground
You ask them for update there is no response but they still let themselves being called “player in the oncology and antiviral spaces”
Not sure what yardstick are they using for calling themselves player
This vitamin company is pushing vitamins. Makes no sense. I can go sell dirt on Amazon, and boost my marketability too.
https://www.benzinga.com/general/biotech/22/08/28684230/sunshine-biopharmas-essential-9-supplement-marks-the-pharma-companys-entry-into-152-billion-dieta
This movie The China Hustle, reminds me of SBFM. It’s like they took a page out of their play book and pulled it off in Canada. After watching it, I couldn’t believe it.
An unsettling and eye-opening Wall Street horror story about Chinese companies, the American stock market, and the opportunistic greed behind the biggest heist you've never heard of.
This scam is heading toward its goal of delisting, then r/s and list again, wash-rinse repeat. Dr Shity is polishing his yacht
Where did Midterner go? I liked that guy, he was a "realistic" bull. That's not good
I think the original estimate was less than 18-24 months... I'm referring to the PowerPoint from the Naz roadshow, but I agree with the rest of your theory.
We must wait.
Sell or chill .
Where the free beer dr slilatcrap??
We lost a mod, midtermer... there's an opening!
Followers
|
760
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
113754
|
Created
|
10/27/08
|
Type
|
Free
|
Moderators |
SUNSHINE BIOPHARMA INC
ANTI CANCER DRUGS
ANTI CORONA VIRUS RESEARCH
SBFM Transfer Agent
Corporate Stock Transfer
3200 Cherry Creek Dr. South
Suite 430
Denver, CO 80209
(303) 282 - 4800 p
(303) 282 - 5800 f
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |